In comparison to samples from a cohort of healthy individuals that were used as controls (Fig. 1a), IL18R1 expression was significantly elevated in patients hospitalized with COVID-19 with no or minimal respiratory dysfunction (P = 0.019). Here, IL18R1 is linked to COVID-19.